GNMLF
Price:
$1.27
Market Cap:
$1.30B
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, U...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-05-04
Stock Exchange
PNK
Ticker
GNMLF
According to Genomma Lab Internacional, S.A.B. de C.V.’s latest financial reports and current stock price. The company's current Dividend Yield is 62.37%. This represents a change of 1.02% compared to the average of 5.56% of the last 4 quarters.
The mean historical Dividend Yield of Genomma Lab Internacional, S.A.B. de C.V. over the last ten years is 8.76%. The current 62.37% Dividend Yield has changed 612.23% with respect to the historical average. Over the past ten years (40 quarters), GNMLF's Dividend Yield was at its highest in in the September 2024 quarter at 18.33%. The Dividend Yield was at its lowest in in the March 2021 quarter at 0%.
Average
8.76%
Median
0%
Minimum
0%
Maximum
72.22%
Discovering the peaks and valleys of Genomma Lab Internacional, S.A.B. de C.V. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 72.22%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 72.22% | 1.41% |
2022 | 4.80% | 166.01% |
2021 | 1.80% | Infinity% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
The current Dividend Yield of Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
26.27%
5-year avg
15.76%
10-year avg
8.76%
Genomma Lab Internacional, S.A.B. de C.V.’s Dividend Yield is less than RAMM Pharma Corp. (0%), greater than Speakeasy Cannabis Club Ltd. (0%), greater than City View Green Holdings Inc. (0%), greater than Craftport Cannabis Corp. (0%), less than Hypera S.A. (1.31%), greater than Indivior PLC (0%), greater than YourWay Cannabis Brands Inc. (0%), greater than Cumberland Pharmaceuticals Inc. (0%), greater than Orexo AB (publ) (0%), greater than Sumitomo Pharma Co., Ltd. (0%), greater than Indivior PLC (0%), greater than C21 Investments Inc. (0%), greater than RavenQuest BioMed Inc. (0%), greater than Bhang Inc. (0%), greater than Willow Biosciences Inc. (0%), greater than Alpha Teknova, Inc. (0%), less than Guardion Health Sciences, Inc. (310.56%), greater than Lifecore Biomedical, Inc. (0%), greater than Organogenesis Holdings Inc. (0%), greater than Petros Pharmaceuticals, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $15.16M | |
0% | $1.31K | |
0% | $3.75M | |
0% | $6.46B | |
1.31% | $2.17B | |
0% | $2.89B | |
0% | $17.82M | |
0% | $14.88M | |
0% | $37.21M | |
0% | $1.51B | |
0% | $3.01B | |
0% | $23.17M | |
0% | $482.11K | |
0% | $23.48K | |
0% | $8.08M | |
0% | $390.75M | |
310.56% | $4.35M | |
0% | $269.21M | |
0% | $536.94M | |
0% | $2.70M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomma Lab Internacional, S.A.B. de C.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genomma Lab Internacional, S.A.B. de C.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Genomma Lab Internacional, S.A.B. de C.V.'s Dividend Yield?
How is the Dividend Yield calculated for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)?
What is the highest Dividend Yield for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)?
What is the 3-year average Dividend Yield for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)?
What is the 5-year average Dividend Yield for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)?
How does the current Dividend Yield for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) compare to its historical average?